article · PubMed

The Correlation of Serum Adropin with Cardiovascular Risk Factors in the Experimental Rat Model of Chronic Kidney Disease and Its Implication in the Ameliorative Effect of Angiotensin-Converting Enzyme Inhibitors.

Samaa AbdEl-Fatah
Enssaf Ahmad Ahmad
Mai Ahmed Gobran
Ashwag Saleh Alsharidah
Sulaiman Mohammed Alnasser
Raja Aljafil
Salim Awadh
Mohammed Alorini
Mohamed Ali Alabiad
Maha Fathy
Enas N. Morgan

2024Open accessZagazig University

Abstract

Adropin levels were significantly correlated with most CVD risk factors in CKD and captopril-treated CKD rats, indicating a role for adropin in the pathogenesis of CVD in CKD. It also refers to its implication in the ameliorative effect of ACEI treatment, possibly by affecting VEGFR-2 and nitric oxide release.

Research topics

Adipose Tissue and Metabolism

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.30476/ijms.2024.99442.3152

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.